AU2018249619A1 - Acoustic perfusion devices - Google Patents
Acoustic perfusion devices Download PDFInfo
- Publication number
- AU2018249619A1 AU2018249619A1 AU2018249619A AU2018249619A AU2018249619A1 AU 2018249619 A1 AU2018249619 A1 AU 2018249619A1 AU 2018249619 A AU2018249619 A AU 2018249619A AU 2018249619 A AU2018249619 A AU 2018249619A AU 2018249619 A1 AU2018249619 A1 AU 2018249619A1
- Authority
- AU
- Australia
- Prior art keywords
- acoustic
- cells
- standing wave
- fluid
- biomolecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000010412 perfusion Effects 0.000 title claims abstract description 152
- 239000012530 fluid Substances 0.000 claims abstract description 209
- 238000000034 method Methods 0.000 claims abstract description 154
- 230000008569 process Effects 0.000 claims abstract description 140
- 239000000203 mixture Substances 0.000 claims abstract description 43
- 239000000463 material Substances 0.000 claims abstract description 40
- 238000009295 crossflow filtration Methods 0.000 claims description 92
- 238000001914 filtration Methods 0.000 claims description 69
- 238000003306 harvesting Methods 0.000 claims description 52
- 230000005855 radiation Effects 0.000 claims description 43
- 238000000926 separation method Methods 0.000 claims description 34
- 238000011144 upstream manufacturing Methods 0.000 claims description 28
- 238000004113 cell culture Methods 0.000 claims description 23
- 230000001225 therapeutic effect Effects 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 14
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 13
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 13
- 238000004587 chromatography analysis Methods 0.000 claims description 10
- -1 polyethylene Polymers 0.000 claims description 6
- 230000003134 recirculating effect Effects 0.000 claims description 6
- 238000011118 depth filtration Methods 0.000 claims description 5
- 230000032258 transport Effects 0.000 claims description 5
- 230000033581 fucosylation Effects 0.000 claims description 4
- 238000011146 sterile filtration Methods 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims 5
- 210000004027 cell Anatomy 0.000 description 305
- 239000000047 product Substances 0.000 description 52
- 239000002245 particle Substances 0.000 description 51
- 230000000694 effects Effects 0.000 description 37
- 238000006073 displacement reaction Methods 0.000 description 34
- 230000014759 maintenance of location Effects 0.000 description 27
- 238000012360 testing method Methods 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000012634 fragment Substances 0.000 description 16
- 230000005284 excitation Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000006143 cell culture medium Substances 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 11
- 229910052782 aluminium Inorganic materials 0.000 description 10
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 10
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 10
- 230000000717 retained effect Effects 0.000 description 10
- 230000035899 viability Effects 0.000 description 10
- 230000004888 barrier function Effects 0.000 description 9
- 230000003833 cell viability Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000013595 glycosylation Effects 0.000 description 7
- 238000006206 glycosylation reaction Methods 0.000 description 7
- 238000004255 ion exchange chromatography Methods 0.000 description 7
- HFGPZNIAWCZYJU-UHFFFAOYSA-N lead zirconate titanate Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2] HFGPZNIAWCZYJU-UHFFFAOYSA-N 0.000 description 7
- 229910052451 lead zirconate titanate Inorganic materials 0.000 description 7
- 238000004088 simulation Methods 0.000 description 7
- 239000004593 Epoxy Substances 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 229910000831 Steel Inorganic materials 0.000 description 6
- 239000000919 ceramic Substances 0.000 description 6
- 238000005352 clarification Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 238000001542 size-exclusion chromatography Methods 0.000 description 6
- 239000010959 steel Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000012466 permeate Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 241000700605 Viruses Species 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 229920001903 high density polyethylene Polymers 0.000 description 4
- 239000004700 high-density polyethylene Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000012780 transparent material Substances 0.000 description 4
- 241000699802 Cricetulus griseus Species 0.000 description 3
- 235000019687 Lamb Nutrition 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 238000010364 biochemical engineering Methods 0.000 description 3
- 238000013406 biomanufacturing process Methods 0.000 description 3
- 238000002659 cell therapy Methods 0.000 description 3
- 230000002301 combined effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000001808 exosome Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000012510 hollow fiber Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- 238000005201 scrubbing Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 231100000023 Cell-mediated cytotoxicity Toxicity 0.000 description 2
- 206010057250 Cell-mediated cytotoxicity Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000005890 cell-mediated cytotoxicity Effects 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 235000021231 nutrient uptake Nutrition 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 230000004845 protein aggregation Effects 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000010408 sweeping Methods 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 238000007514 turning Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 101100454807 Caenorhabditis elegans lgg-1 gene Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 230000012478 N-glycan fucosylation Effects 0.000 description 1
- 240000007182 Ochroma pyramidale Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005276 aerator Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000011129 allogeneic cell therapy Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000011130 autologous cell therapy Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000012444 downstream purification process Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000003893 lactate salts Chemical group 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002569 water oil cream Substances 0.000 description 1
- 230000005428 wave function Effects 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/10—Separation or concentration of fermentation products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2022201183A AU2022201183A1 (en) | 2017-04-06 | 2022-02-22 | Acoustic perfusion devices |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482681P | 2017-04-06 | 2017-04-06 | |
| US62/482,681 | 2017-04-06 | ||
| US15/696,176 US10662402B2 (en) | 2012-03-15 | 2017-09-05 | Acoustic perfusion devices |
| US15/696,176 | 2017-09-05 | ||
| US201762563068P | 2017-09-26 | 2017-09-26 | |
| US62/563,068 | 2017-09-26 | ||
| PCT/US2018/026617 WO2018187789A1 (fr) | 2017-04-06 | 2018-04-06 | Dispositifs de perfusion acoustique |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022201183A Division AU2022201183A1 (en) | 2017-04-06 | 2022-02-22 | Acoustic perfusion devices |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2018249619A1 true AU2018249619A1 (en) | 2020-10-15 |
Family
ID=63712638
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018249619A Abandoned AU2018249619A1 (en) | 2017-04-06 | 2018-04-06 | Acoustic perfusion devices |
| AU2022201183A Abandoned AU2022201183A1 (en) | 2017-04-06 | 2022-02-22 | Acoustic perfusion devices |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022201183A Abandoned AU2022201183A1 (en) | 2017-04-06 | 2022-02-22 | Acoustic perfusion devices |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3638765A1 (fr) |
| AU (2) | AU2018249619A1 (fr) |
| CA (1) | CA3082019A1 (fr) |
| SG (1) | SG11202003765RA (fr) |
| WO (1) | WO2018187789A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201908612D0 (en) * | 2019-06-17 | 2019-07-31 | Ge Healthcare Bio Sciences Ab | A method for separating biomolecules |
| DE102020002499A1 (de) * | 2020-04-26 | 2021-10-28 | Smart Material Printing B.V. | Vorrichtung und Verfahren zur Reinigung und Wiedergewinnung gebrauchter Schmierstoffe und/oder Kühlschmierstoffe |
| EP4547811A1 (fr) * | 2022-06-30 | 2025-05-07 | Genentech Inc. | Systèmes, appareil et procédés de culture cellulaire |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2851053A1 (fr) * | 2011-10-19 | 2013-04-25 | Roche Glycart Ag | Procede de separation d'anticorps fucosyles |
| US9822333B2 (en) * | 2012-03-15 | 2017-11-21 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| WO2015102528A1 (fr) * | 2013-12-30 | 2015-07-09 | Ge Healthcare Bio-Sciences Corp. | Dispositif de culture cellulaire |
| WO2016187596A1 (fr) * | 2015-05-20 | 2016-11-24 | Flodesign Sonics, Inc. | Manipulation acoustique de particules dans des champs d'ondes stationnaires |
-
2018
- 2018-04-06 SG SG11202003765RA patent/SG11202003765RA/en unknown
- 2018-04-06 WO PCT/US2018/026617 patent/WO2018187789A1/fr not_active Ceased
- 2018-04-06 CA CA3082019A patent/CA3082019A1/fr active Pending
- 2018-04-06 EP EP18720727.9A patent/EP3638765A1/fr active Pending
- 2018-04-06 AU AU2018249619A patent/AU2018249619A1/en not_active Abandoned
-
2022
- 2022-02-22 AU AU2022201183A patent/AU2022201183A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018187789A1 (fr) | 2018-10-11 |
| EP3638765A1 (fr) | 2020-04-22 |
| AU2022201183A1 (en) | 2022-03-17 |
| SG11202003765RA (en) | 2020-05-28 |
| CA3082019A1 (fr) | 2018-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10662402B2 (en) | Acoustic perfusion devices | |
| US9738866B2 (en) | Acoustic perfusion devices | |
| US9822333B2 (en) | Acoustic perfusion devices | |
| US10947493B2 (en) | Acoustic perfusion devices | |
| US9752114B2 (en) | Bioreactor using acoustic standing waves | |
| US9783775B2 (en) | Bioreactor using acoustic standing waves | |
| EP3234099B1 (fr) | Dispositifs acoustiques de perfusion | |
| US20170191022A1 (en) | Bioreactor using acoustic standing waves | |
| US10704021B2 (en) | Acoustic perfusion devices | |
| US10689609B2 (en) | Acoustic bioreactor processes | |
| EP3360955A1 (fr) | Bioréacteur utilisant des ondes stationnaires acoustiques | |
| AU2022201183A1 (en) | Acoustic perfusion devices | |
| EP3426372A1 (fr) | Dispositif d'acoustophorèse à plusieurs étages | |
| CA3013052A1 (fr) | Dispositifs de perfusion acoustique | |
| CN109069954B (zh) | 多站式声泳装置 | |
| EP3341463B1 (fr) | Dispositifs de perfusion acoustiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NA | Applications received for extensions of time, section 223 |
Free format text: AN APPLICATION TO EXTEND THE TIME FROM 06 NOV 2019 TO 06 MAY 2020 IN WHICH TO ENTER THE NATIONAL PHASE HAS BEEN FILED |
|
| NB | Applications allowed - extensions of time section 223(2) |
Free format text: THE TIME IN WHICH TO ENTER THE NATIONAL PHASE HAS BEEN EXTENDED TO 06 MAY 2020 |
|
| PC1 | Assignment before grant (sect. 113) |
Owner name: FLODESIGN SONICS, INC. Free format text: FORMER APPLICANT(S): BROWER, MARK; FLODESIGN SONICS, INC. |
|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |